Streamex Corp. (STEX) Material Update (8-K)

Critical Event: Nasdaq granted formal approval for the continued listing of common stock (STEX) on The Nasdaq Capital Market.

• The company (formerly BioSig) focuses on institutional commodity tokenization.

Investors must note the upcoming shareholder action:

• Reconvened Special Meeting: November 4, 2025, 3:00 PM ET.
• The sole focus is the formal vote on Proposal 1 – The Acquisition Proposal.

Management noted the listing allows acceleration of business plans and unlocking opportunities for **GLDY stablecoin